Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Net Cash Flow (2024 - 2025)

Beta Bionics (BBNX) has disclosed Net Cash Flow for 2 consecutive years, with -$6.9 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 153.35% to -$6.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, down 70.41% year-over-year, with the annual reading at $1.1 million for FY2025, 70.41% down from the prior year.
  • Net Cash Flow hit -$6.9 million in Q4 2025 for Beta Bionics, down from $3.4 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $13.0 million in Q4 2024 to a low of -$9.0 million in Q2 2024.